Risk of hypoglycemia in older veterans with dementia and cognitive impairment: Implications for practice and policy

Journal of the American Geriatrics Society

Volumn 59, Issue 12, 2011, Pages 2263-2272

  Feil, Denise G ^a,b   Rajan, Mangala ^c   Soroka, Orysya ^c   Tseng, Chin Lin ^c,d   Miller, Donald R ^e,f   Pogach, Leonard M ^c,d  

^a West Los Angeles Veterans Affairs Healthcare Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e BOSTON UNIVERSITY   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

cognitive impairment; dementia; diabetes mellitus; glycemic control; hypoglycemia

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

AGED; ARTICLE; COGNITIVE DEFECT; DEMENTIA; DIABETES MELLITUS; HEALTH CARE POLICY; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; OUTCOME ASSESSMENT; PREVALENCE; VETERAN;

AGED; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DEMENTIA; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPOGLYCEMIA; MALE; RISK FACTORS; VETERANS;

EID: 84155171098     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03726.x     Document Type: Article

References (51)

1. Cukierman T, Gerstein HC, Williamson JD,. Cognitive decline and dementia in diabetes-Systematic overview of prospective observational studies. Diabetologia 2005; 48: 2460-2469. (Pubitemid 41738208)
2. Fontbonne A, Berr C, Ducimetiere P, et al. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: Results of the Epidemiology of Vascular Aging Study. Diabetes Care 2001; 24: 366-370. (Pubitemid 32119140)
3. MacKnight C, Rockwood K, Awalt E, et al. Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 2002; 14: 77-83. (Pubitemid 36152948)
4. Elias PK, Elias MF, D'Agostino RB, et al. NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care 1997; 20: 1388-1395. (Pubitemid 27366813)
5. Roberts RO, Geda YE, Knopman DS, et al. Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol 2008; 65: 1066-1073.
6. Stewart R, Liolitsa D,. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 1999; 16: 93-112.
7. Strachan MW, Deary IJ, Ewing FM, et al. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies Diabetes Care 1997; 20: 438-445. (Pubitemid 27098239)
8. deWet H, Levitt N, Tipping B,. Executive cognitive impairment detected by simple bedside testing is associated with poor glycaemic control in type 2 diabetes. S Afr Med J 2007; 97: 1074-1076. (Pubitemid 350285951)
9. Feil DG, Pearman A, Victor T, et al. The role of cognitive impairment and caregiver support in diabetes management of older outpatients. Int J Psychiatry Med 2009; 39: 199-214.
10. Munshi M, Grande L, Hayes M, et al. Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care 2006; 29: 1794-1799. (Pubitemid 44156632)
11. Rosen MI, Beauvais JE, Rigsby MO, et al. Neuropsychological correlates of suboptimal adherence to metformin. J Behav Med 2003; 26: 349-360. (Pubitemid 36890201)
12. Walker EA, Molitch M, Kramer MK, et al. Adherence to preventive medications: Predictors and outcomes in the Diabetes Prevention Program. Diabetes Care 2006; 29: 1997-2002. (Pubitemid 44871177)
13. Boise L, Camicioli R, Morgan DL, et al. Diagnosing dementia: Perspectives of primary care physicians. Gerontologist 1999; 39: 457-464. (Pubitemid 29427212)
14. Callahan CM, Hendrie HC, Tierney WM,. Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann Intern Med 1995; 122: 422-429.
15. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
16. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129-139.
17. Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559. (Pubitemid 351831356)
18. Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572. (Pubitemid 351831357)
19. Bonds DE, Miller ME, Bergenstal RM, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: Retrospective epidemiological analysis of the ACCORD study. BMJ 2010; 340: b4909.
20. Zoungas S, Patel A, Chalmers J, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010; 363: 1410-1418.
21. The American Geriatric Society Guidelines for Improving the Care of the Older Person with Diabetes Mellitus; California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes [on-line]. Available at Accessed November 13, 2011.
22. National Committee for Quality Assurance-HEDIS, 2010 Technical Specifications, Vol. 2. Washington, DC: National Committee for Quality Assurance-HEDIS, 2010.
23. Chaudhry SI, Berlowitz DR, Concato J,. Do age and comorbidity affect intensity of pharmacological therapy for poorly controlled diabetes mellitus? J Am Geriatr Soc 2005; 53: 1214-1216. (Pubitemid 41632524)
24. Suh DC, Kim CM, Choi IS, et al. Comorbid conditions and glycemic control in elderly patients with type 2 diabetes mellitus, 1988 to 1994 to 1999 to 2004. J Am Geriatr Soc 2008; 56: 484-492.
25. Budnitz DS, Shehab N, Kegler SR, et al. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007; 147: 755-765. (Pubitemid 351664440)
26. Moore TJ, Cohen MR, Furberg CD,. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. Arch Intern Med 2007; 167: 1752-1759. (Pubitemid 47403063)
27. Hemmelgarn B, Levesque LE, Suissa S,. Anti-diabetic drug use and the risk of motor vehicle crash in the elderly. Can J Clin Pharmacol 2006; 13: e112-e120. (Pubitemid 46165606)
28. Pogach L, Aron D,. Balancing hypoglycemia and glycemic control: A public health approach for insulin safety. JAMA 2010; 303: 2076-2077.
29. Miller DR, Safford MM, Pogach LM,. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care 2004; 27 (Suppl 2): B10-B21. (Pubitemid 38569259)
30. Veterans Administration Dementia Registry Task Force. VA Dementia Registry Methods Report; summary data tables on demographics, service use, and costs 2004 April 2.
31. U.S. Department of Health and Human Services. 2008 National Healthcare Disparities and Quality Reports. U.S. Department of Health and Human Services, 2008. Report No.: AHRQ Publication No. 09-0002.
32. Ginde AA, Blanc PG, Lieberman RM, et al. Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits. BMC Endocr Disord 2008; 8: 4.
33. Shen Y, Hendricks A, Zhang S, et al. VHA enrollees' health care coverage and use of care. Med Care Res Rev 2003; 60: 253-267. (Pubitemid 36605436)
34. Meduru P, Helmer D, Rajan M, et al. Chronic illness with complexity: Implications for performance measurement of optimal glycemic control. J Gen Intern Med 2007; 22 (Suppl 3): 408-418. (Pubitemid 350172455)
35. Piette JD, Kerr EA,. The impact of comorbid chronic conditions on diabetes care. Diabetes Care 2006 Mar; 29: 725-731. (Pubitemid 44115387)
36. Bruce DG, Davis WA, Casey GP, et al. Severe hypoglycaemia and cognitive impairment in older patients with diabetes: The Fremantle Diabetes Study. Diabetologia 2009; 52: 1808-1815.
37. Poehlman ET, Dvorak RV,. Energy expenditure, energy intake, and weight loss in Alzheimer disease. Am J Clin Nutr 2000; 71: 650S-655S. (Pubitemid 30061251)
38. Shorr RI, Ray WA, Daugherty JR, et al. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997; 157: 1681-1686. (Pubitemid 27327403)
39. Feil DG, Zhu CW, Sultzer DL,. The relationship between cognitive impairment and diabetic self-management in a population-based community sample of older adults with diabetes. J Behav Med 2011 [Epub ahead of print].
40. Helmer D, Sambamoorthi U, Shen Y, et al. Opting out of an integrated healthcare system: Dual-system use is associated with poorer glycemic control in veterans with diabetes. Prim Care Diabetes 2008; 2: 73-80.
41. Aspinall SL, Banthin JS, Good CB, et al. VA pharmacy users: How they differ from other veterans. Am J Manag Care 2009; 15: 701-708.
42. Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009; 301: 1565-1572.
43. Agency for Healthcare Research and Quality. Assessing Quality of Care for Diabetes, Conference Final Report. U.S. Department of Health and Human Services, 2008 January.
44. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010; 33 (Suppl 1): S11-S61.
45. Cornali C, Franzoni S, Di F, et al. Implementation of guidelines for type 2 diabetes mellitus in a post-acute geriatric setting. Aging Clin Exp Res 2009; 21: 338-343.
46. Little RR, Rohlfing CL, Sacks DB,. Status of hemoglobin A1c measurement and goals for improvement: From chaos to order for improving diabetes care. Clin Chem 2011; 57: 205-214.
47. Lenters-Westra E, Slingerland RJ,. Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria. Clin Chem 2010; 56: 44-52.
48. Centers for Disease Control and Prevention, 2003. National Diabetes Fact Sheet. 2003 January 1 [on-line]. Available at Accessed April 5, 2011.
49. Pogach L, Aron DC,. Sudden acceleration of diabetes quality measures. JAMA 2011; 305: 709-710, in press.
50. Bayley M, Lindsay P, Hellings C, Woodbury E, Phillips S,. Balancing evidence and opinion in stroke care: the 2008 best practice recommendations. Can Med Assoc J 2008; 179: 1247-1249.
51. Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006; 37: 2220-2241. (Pubitemid 44337162)